BRG1 plays a critical role in driving cancer-specificmetabolic pathways in breast cancer and is linked to different signalingpathways that promote colorectal and pancreatic cancer, neuroblastoma,medulloblastoma and melanoma. This evidence concerns the gene SMARCA4 and breast carcinoma.